Helicobacter mustelae (H. mustelae)

Helicobacter mustelae is a Gram-negative, microaerophilic, spiral-shaped bacterium that serves as a primary gastric pathogen in ferrets (PubMed, PMID: 1473212). It is highly prevalent in ferret populations and is known to cause chronic atrophic gastritis and peptic ulcer disease by colonizing the pyloric antrum and inducing a significant inflammatory response (Vetlexicon). The organism is particularly notable in biomedical research because it mimics the clinical and pathological features of Helicobacter pylori infection in humans, including the potential to progress to gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma (PMC, PMC2806659). Eradication of the bacterium is typically achieved through combination therapies involving antibiotics such as amoxicillin and metronidazole, often supplemented with gastroprotectants like bismuth subsalicylate or proton pump inhibitors (PubMed, PMID: 8143666). While it is a focus of clinical and veterinary treatment, Helicobacter mustelae is a bacterial organism rather than a single molecular target such as a receptor or enzyme. Consequently, therapeutic strategies target multiple bacterial processes or the gastric microenvironment to eliminate the pathogen (ResearchGate).

Other names

Campylobacter pylori subsp. mustelaeH. mustelae

Antibiotics inhibit bacterial cell wall synthesis (amoxicillin) or DNA synthesis (metronidazole), while proton pump inhibitors and bismuth compounds modulate gastric acidity and provide mucosal protection to facilitate bacterial eradication (PubMed, PMID: 8143666).